Vytrus Biotech, S.A. (BME:VYT)
3.300
0.00 (0.00%)
At close: May 9, 2025, 5:30 PM CET
Vytrus Biotech Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Cash & Equivalents | 2.22 | 1.1 | 0.72 | 1.28 | 1.09 | 0.83 | Upgrade
|
Short-Term Investments | 0 | 0 | - | 0 | 0 | 0 | Upgrade
|
Cash & Short-Term Investments | 2.22 | 1.11 | 0.72 | 1.28 | 1.09 | 0.83 | Upgrade
|
Cash Growth | 97.97% | 52.54% | -43.56% | 17.37% | 31.98% | 244.14% | Upgrade
|
Accounts Receivable | 0.6 | 0.55 | 0.44 | 0.21 | 0.17 | 0.13 | Upgrade
|
Other Receivables | 0.18 | 0.23 | 0.09 | 0.05 | 0.05 | 0.03 | Upgrade
|
Receivables | 0.78 | 0.78 | 0.53 | 0.27 | 0.21 | 0.16 | Upgrade
|
Inventory | 0.51 | 0.56 | 0.43 | 0.26 | 0.21 | 0.17 | Upgrade
|
Other Current Assets | 0.03 | - | - | 0.01 | 0.02 | - | Upgrade
|
Total Current Assets | 3.53 | 2.45 | 1.68 | 1.82 | 1.54 | 1.16 | Upgrade
|
Property, Plant & Equipment | 0.9 | 0.93 | 1.03 | 0.68 | 0.57 | 0.49 | Upgrade
|
Long-Term Investments | 0.08 | 0.09 | 0.07 | 0.04 | 0.01 | 0.01 | Upgrade
|
Other Intangible Assets | 3.9 | 3.63 | 3.15 | 2.84 | 2.53 | 2.25 | Upgrade
|
Long-Term Deferred Tax Assets | 2.23 | 2.22 | 2.07 | 1.81 | 1.55 | 1.33 | Upgrade
|
Other Long-Term Assets | - | - | - | - | - | 0 | Upgrade
|
Total Assets | 10.64 | 9.31 | 8 | 7.18 | 6.21 | 5.24 | Upgrade
|
Accounts Payable | 0.03 | 0.04 | 0.17 | 0.16 | 0.08 | 0.06 | Upgrade
|
Accrued Expenses | 0.15 | 0.07 | 0.17 | 0.16 | 0.05 | - | Upgrade
|
Current Portion of Long-Term Debt | 0.44 | 0.34 | 0.25 | 0.19 | 0.2 | 0.24 | Upgrade
|
Other Current Liabilities | 0.45 | 0.54 | 0.68 | 0.29 | 0.32 | 0.15 | Upgrade
|
Total Current Liabilities | 1.08 | 1 | 1.27 | 0.81 | 0.64 | 0.46 | Upgrade
|
Long-Term Debt | 1.58 | 1.73 | 0.74 | 0.74 | 0.67 | 0.97 | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.59 | 0.66 | 0.69 | 0.59 | 0.47 | 0.38 | Upgrade
|
Other Long-Term Liabilities | 0.58 | 0.63 | 0.55 | 0.8 | 0.82 | - | Upgrade
|
Total Liabilities | 3.84 | 4.02 | 3.25 | 2.93 | 2.6 | 1.8 | Upgrade
|
Common Stock | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | Upgrade
|
Additional Paid-In Capital | 4.63 | 3.4 | 3.4 | 3.4 | 3.15 | 3.15 | Upgrade
|
Retained Earnings | 2.13 | 1.45 | 1.21 | 0.7 | 0.1 | -0.12 | Upgrade
|
Treasury Stock | -0.24 | -0.9 | -0.59 | -0.23 | -0.03 | -0 | Upgrade
|
Comprehensive Income & Other | 0.22 | 1.26 | 0.66 | 0.31 | 0.32 | 0.34 | Upgrade
|
Shareholders' Equity | 6.81 | 5.29 | 4.75 | 4.25 | 3.61 | 3.44 | Upgrade
|
Total Liabilities & Equity | 10.64 | 9.31 | 8 | 7.18 | 6.21 | 5.24 | Upgrade
|
Total Debt | 2.03 | 2.08 | 0.98 | 0.93 | 0.87 | 1.21 | Upgrade
|
Net Cash (Debt) | 0.19 | -0.97 | -0.26 | 0.35 | 0.22 | -0.38 | Upgrade
|
Net Cash Growth | - | - | - | 57.68% | - | - | Upgrade
|
Net Cash Per Share | 0.03 | -0.14 | - | 0.05 | 0.03 | -0.05 | Upgrade
|
Filing Date Shares Outstanding | 7.54 | 6.74 | - | 6.93 | 6.9 | 6.96 | Upgrade
|
Total Common Shares Outstanding | 7.54 | 6.74 | - | 6.93 | 6.9 | 6.96 | Upgrade
|
Working Capital | 2.46 | 1.46 | 0.41 | 1.01 | 0.89 | 0.7 | Upgrade
|
Book Value Per Share | 0.90 | 0.79 | - | 0.61 | 0.52 | 0.49 | Upgrade
|
Tangible Book Value | 2.91 | 1.66 | 1.6 | 1.42 | 1.08 | 1.19 | Upgrade
|
Tangible Book Value Per Share | 0.39 | 0.25 | - | 0.20 | 0.16 | 0.17 | Upgrade
|
Buildings | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | - | Upgrade
|
Machinery | 1.33 | 1.27 | 1.32 | 0.88 | 0.7 | - | Upgrade
|
Construction In Progress | - | 0.01 | 0.01 | - | - | 0.09 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.